scholarly article | Q13442814 |
P50 | author | Maria Del Zompo | Q43303007 |
Donatella Congiu | Q43303034 | ||
P2093 | author name string | Carlo Asuni | |
Allesandra Cherchi | |||
Maria E Stochino | |||
Maria P Piccardi | |||
P2860 | cites work | Human monoamine oxidase A gene determines levels of enzyme activity | Q24678322 |
Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients | Q28274131 | ||
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region | Q28297391 | ||
A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia | Q28307335 | ||
The impact of pharmacogenetics for migraine | Q31925619 | ||
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials | Q34647375 | ||
Therapeutic implications of central and peripheral neurologic mechanisms in migraine | Q35569301 | ||
Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response. | Q39461967 | ||
Dopamine and migraine | Q41598488 | ||
The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor | Q43592479 | ||
Mapping of the serotonin 5-HT1D beta autoreceptor gene on chromosome 6 and direct analysis for sequence variants. | Q52208892 | ||
Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor | Q55049552 | ||
Monte Carlo tests for associations between disease and alleles at highly polymorphic loci | Q60627367 | ||
Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels | Q73230740 | ||
Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles | Q73508519 | ||
Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial | Q73883809 | ||
5-HT1B receptor polymorphism and clinical response to sumatriptan | Q74574599 | ||
Neurogenic control of the cerebral microcirculation: is dopamine minding the store? | Q77295945 | ||
Association between dopamine receptor genes and migraine without aura in a Sardinian sample | Q77332492 | ||
P433 | issue | 3 | |
P304 | page(s) | 185-189 | |
P577 | publication date | 2007-06-11 | |
P1433 | published in | The journal of headache and pain : official journal of the Italian Society for the Study of Headaches | Q26842211 |
P1476 | title | Association study between clinical response to rizatriptan and some candidate genes | |
P478 | volume | 8 |
Q48226245 | Association of RAMP1 rs7590387 with the risk of migraine transformation into medication overuse headache |
Q38108482 | Dopaminergic symptoms in migraine |
Q36261201 | Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine |
Q37818258 | Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy |
Q35563650 | Genetic Polymorphisms in the Dopamine Receptor 2 Predict Acute Pain Severity after Motor Vehicle Collision |
Q44921069 | Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility |
Q84979035 | Migraine general aspects |
Q39720265 | Negative predictors of clinical response to triptans in patients with migraine |
Q44613289 | New genetic evidence for involvement of the dopamine system in migraine with aura |
Q37064080 | Pharmacogenomics and migraine: possible implications |
Q38195629 | Pharmacogenomics of episodic migraine: time has come for a step forward. |
Q44739665 | Refractory migraine and chronic migraine: pathophysiological mechanisms |
Q38096945 | Triptan nonresponders: do they exist and who are they? |